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Abstract
Background: The goal of this study is to compare quality of life (Qol) and symptoms in 91 patients with a deviated
nasal septum preoperatively and postoperatively with a control group of 93 healthy individuals.
Methods: All patients reported Qol on Sino-Nasal-Outcome-Test-20 (SNOT-20) and symptoms on visual analogue
scale (VAS) preoperatively and 6 months after surgery and the results were compared with the controls.
Results: Mean SNOT-20 score improved from 1.8(SD0.9) preoperatively to 0.9(SD0.8) postoperatively (p < 0.000) but
did not reach the same level as the controls 0.4(SD0.5). Septum surgery leads to a significant symptom improvement
for all symptoms investigated (p < 0.000) on VAS. The patients reached the same level as the healthy controls in 6 of 11
symptoms (headache, facial pain, sneezing, trouble with rhinosinusitis, cough and snoring) but the patients group had
significantly more trouble with nasal blockage (VAS 29 vs 9), change in sense of smell (VAS 12 vs5), nasal discharge
(VAS 22 vs 11), oral breathing (VAS 23 vs 13) and reduced general health (VAS 12 vs 5) also postoperatively (p < 0.01).
Sub analyses showed that allergic patients reported a VAS score of 36 (SD30) for nasal blockage and 17 (SD22) for facial
pressure postoperatively versus 23(SD22) and 6(SD13) in non-allergic patients (p < 0.03 and p < 0.01). Patients with
obstructive sleep apnea syndrome (OSAS) reported more trouble with snoring on VAS postoperatively than other
patients, 42(SD28) versus 20(SD23) (p < 0.002).
Conclusion: Septoplasty leads to a highly significant improvement in Qol and symptoms. The patients do not reach
the same level of Qol as healthy controls. All symptoms are reported as mild on VAS postoperatively.
Allergic patients tend to report more nasal blockage and facial pressure postoperatively than other patients and a focus
on medical treatment should be kept also postoperatively. Patients with obstructive sleep apnea report more trouble
with snoring postoperatively and alterative treatment options for snoring may be considered in these patients.
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Background
Nasal blockage is a common complaint. In the adult
population chronic diseases such as chronic rhinosinusi-
tis and allergic rhinitis are two of the main causes for
nasal congestion. In Europe, chronic rhinosinusitis has a
prevalence of 10,9 % [1] and allergic rhinitis a prevalence
of 17–29 % [2]. These diseases cause mucosal congestion
and lead to nasal obstruction with reduced nasal airflow.
Other causes for nasal blockage may be structural, where
variations of the cartilaginous and bony structures of the
nose can lead to problems with reduced nasal airflow.
Nasal septal deviations have a prevalence ranging from
19 to 65 % due to different criteria for defining a devi-
ated septum [3, 4].
Some patients with a deviated septum need surgery to
relieve symptoms. Nasal septoplasty is the third most
common surgery [5] performed in the ear nose and
throat (ENT) specialty and can be done under local or
general anesthesia. Nevertheless, the gain of this surgery
has been questioned. Some studies have showed moder-
ate to excellent results [6, 7] but a new study from
Sweden suggests that the results are unsatisfactory [8].
Additionally, radiofrequency therapy of the inferior tur-
binate is done frequently as an attempt to reduce nasal
congestion or hypertrophy of the inferior turbinate [9].
Other procedures to reduce the size of the inferior tur-
binate turbinate can be complete or partly resection of
the turbinate or use of instruments as the microdebri-
ders, laser or bipolar diathermy.
In 2012 our department started a quality register to
evaluate the results of nasal surgery. The scope of the
register is to evaluate our results after existing or new
surgical procedures or measures and hence improve
daily praxis and treatment plans to the best for our
patients.
The primary goal of this study is to compare the Qol
and symptoms in patients undergoing septoplasty with
or without surgery of the inferior turbinate with Qol and
symptoms in healthy individuals. Secondary we evaluate
the effect of surgery on QoL and symptoms in the pa-
tient group.
Materials and methods
Ethics, consent and permissions
This prospective study has been conducted during the
period from January 2012 to April 2015 and is approved
by the Committee for Medical Research Ethics in Norway,
2015/367/REK NORD. All patients and controls signed a
written consent prior to inclusion in the trial.
Materials
All patients were referred to the ENT department at St
Olav’s Hospital/Trondheim University hospital from
general practitioners, ENT specialists or other hospitals
in the region. All patients were examined at the out-
patient clinic by a variety of surgeons. The diagnosis was
based on endoscopic examination of the nose combined
with patients’ symptoms. When there was indication for
septoplasty alone or septoplasty combined with radiofre-
quenzy therapy of the inferior turbinate, the patients
were asked to participate in the study. Inclusion criteria
were a deviated nasal septum with nasal breathing
problems. Exclusion criteria were age less than 18 years
and language problems with difficulty to interpret the
questionnaires.
We included 103 patients with septal deviation. Twelve
patients did not attend for surgery. Thus 91 patients
underwent surgery and 86 came for the postoperative
control 6 months after surgery. Ninety three healthy indi-
viduals without nasal complaints were used as controls.
Methods
Quality of life and symptoms preoperatively and 6 months
postoperatively
Quality of life was assessed with the Sino-Nasal-
Outcome-Test-20 (SNOT 20) questionnaire which is a
validated disease specific Qol questionnaire for rhino-
sinusitis [10, 11]. The patients graded 20 symptoms on a
scale from 0 (no symptoms) to 5 (problem as severe as
can be). The SNOT score for each patient was defined as
the mean value of the response to the 20 items. The
questionnaire is divided into 4 subsets [12]. The first
subset includes symptoms related to nose, the second
subset focuses on ear and face, the third subset considers
sleep quality and the fourth subset has questions about
psychological issues.
Symptoms were reported on 100 mm visual analog
scales (VASs) where 0 mm represents no symptoms and
100 mm represent “as troublesome as possible”. Symp-
toms reported are nasal obstruction, headache, facial pain,
facial pressure, reduced sense of smell, nasal discharge,
sneezing, cough, snoring, and oral breathing and reduced
general health. The symptom severity is considered mild
between 0 and 30, moderate from 30 to 70 and severe
from 70- 100 [13].
Patient satisfaction
The patients were asked if they were satisfied with the
results of surgery 6 months after surgery. They answered
the question with yes or no.
Statistics
Descriptive results are presented as mean with standard
deviation (SD) or range. We used exact test to compare
ordinal and categorical variables. In the statistical ana-
lyses we used paired samples T test to compare mean
values preoperatively and postoperatively in the patient
group. To compare mean values in the control group
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with the mean postoperative values in the patient group,
we used independent samples T test. In additional ana-
lyses, we also used a general linear model to adjust for
potential differences in the distribution of age and sex in
the groups.
We have done power calculations. It showed that with
40 patients in each group and a significance level of
0.05(alpha), we were able to detect a difference in
SNOT-20 of 0.6 (SD 1.2) between the groups with 80 %
power. With 100 participants in each group and the
same assumptions as above, we were able to detect a dif-
ference in SNOT-20 of 0.4.
All statistical analysis was performed using PASW
Statistics, version 22 for Windows (SPSS Inc., Chicago,
Illinois) and a two—sided p-value less than 0.05 was
considered significant.
Results
Baseline information of the patients and control group
are given in Table 1.
Surgical procedure and postoperative care
Twenty one patients underwent surgery under local
anesthesia and 70 had general anesthesia. Average time
for the surgery was 76 min (range 10–153). Fifty-one pa-
tients underwent traditional cartilage preserving septo-
plasty alone and 40 patients had a combination of
septoplasty and radiofrequency therapy of the inferior
tubinates. The procedures were done by 13 different sur-
geons, 6 consultants and 7 senior registrars. Seventy-seven
(77/91) had a silastic plate bilaterally for support and to
prevent adhesions postoperatively. Forty-three patients
had a nasal packing for approximately 2 days postopera-
tively to prevent bleeding and septum hematoma. The
nasal packing was removed by a nurse in the outpatient
clinic or by the patients themselves. The plates were taken
out approximately 1 week after surgery by the surgeon.
Sino Nasal Outcome Test (SNOT-20) before- and 6 months
after surgery
SNOT 20 showed a significant reduction for all symp-
toms included in the test (Table 2). Average SNOT-20
score was 1.8 (SD 0.9) preoperatively and 0.9 (SD 0.80)
postoperatively (p < 0.000). We found highly significant
improvements for all four subsets. Sleep function
seemed to improve better than the items from the nose
and psychological subsets. The items from the subset of
ears and face had a smaller absolute improvement than
the other subsets but also this subset improved signifi-
cantly after surgery. When we compared the postopera-
tive SNOT score from the patients with the SNOT score
in the healthy control group, we found that the control
group had less trouble with most of the items in the
questionnaire. Nevertheless, it was interesting to find no
significant differences between the patients and healthy
controls in the Ear and face subset of the SNOT-20
questionnaire postoperatively (Table 2). In additional
multivariable analyses, we also adjusted for age and sex,
but this did not change the results.
Symptoms on visual analog scales (VASs) before and
6 months after surgery
Regarding symptoms given on VAS we found that
septum surgery leads to a significant symptom improve-
ment for all symptoms investigated (Table 3). We com-
pared postoperative symptoms in the patient group with
symptoms in the control group and found that the pa-
tients group had significantly more trouble with nasal
blockage, change in sense of smell, nasal discharge, oral
breathing and reduced general health also postoperatively
(Table 3). Additional multivariable analyses with adjust-
ments for age and sex were done without change in the
results. We also did sub analyses, where patients who have
had septoplasty alone where compared with those who
had septoplasty combined with radiofrequency therapy of
the inferior turbinate. No significant differences in SNOT
scores and postoperative symptoms between the groups
were shown.
Allergy
We compared mean postoperative total SNOT-20 values
in the allergic patients (1.0 (SD 0.9)) with non-allergic
patients (0.9 (SD 0.7)) and found no significant differences
(p = 0.47). We also compared preoperative and postopera-
tive symptoms in allergic and non-allergic patients. Pre-
operatively there were no differences between the groups
but postoperatively the allergic patients were significantly
more bothered with nasal blockage (p = 0.03) and facial
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pressure (p = 0.01) than the non-allergic patients. The
allergic patients reported a mean value of 36 (SD30) on
VAS for nasal blockage postoperatively and the non-
allergic patients reported 23 (SD22) on VAS. For facial
pressure the values on VAS were 17 (SD26) in allergic
versus 6 (SD13) in the non-allergic patients.
Asthma
Mean postoperative total SNOT-20 value in the fourteen
asthma patients was 1.0 (SD 0.8) versus 0.9 (SD 0.8) in
the non- asthmatic patients (p < 0.55). We also compared
postoperative symptoms in asthmatic and non-asthmatic
patients and found no significant differences between the
groups postoperatively.
Obstructive sleep apnea syndrome (OSAS)
Fifteen patients reported they had obstructive sleep
apnea syndrome (OSAS) preoperatively. We compared
mean postoperative total SNOT-20 values in OSAS pa-
tients and non-OSAS patients and found no significant
differences (p = 0.18). Mean values in the OSAS patients
were 1.0 (SD 0.8) and 0.9 (SD 0.8) in patients without
OSAS. We also compared postoperative symptoms in
patients with OSAS with patients without OSAS. We
found that OSAS patients report significantly more
trouble with snoring postoperatively than other patients
(p < 0.002). The OSAS patients reported a mean VAS
score for snoring of 40 (SD 29) postoperatively com-
pared to a mean VAS score of 20 (SD 24) in the other
patients after surgery.
Table 2 presents mean values on SNOT 20 in the patient group and in the control group
Question Mean pre-operative score Mean post-operative score P-valueA Mean score Control group P ValueB
Need to blow nosea 2.8(1.3) 1.7(1.3) 0.000 0.6(0.8) 0.000
Sneezinga 1.77(1.3) 1.0(1.0) 0.000 0.5(0.7) 0.000
Runny nosea 2.0(1.5) 1.0(1.1) 0.000 0.4(0.7) 0.000
Cough 1.2(1.2) 0.7(0.9) 0.000 0.3(0.7) 0.005
Postnasal dischargea 1.6(1.4) 0.9(1.3) 0.000 0.2(0.6) 0.000
Thick nasal dischargea 1.9(1.5) 1.0(1.3) 0.000 0.2(0.5) 0.000
Ear fullnessb 1.2(1.3) 0.7(1.1) 0.000 0.6(1.1) 0.4
Dizzinessb 1.0(1.2) 0.4(0.7) 0.000 0.4(0.8) 0.4
Ear painb 0.7(1.1) 0.4(0.9) 0.01 0.4(0.9) 0.9
Facial pain/pressureb 1.2(1.4) 0.4(0.9) 0.000 0.2(0.5) 0.05
Difficulty falling to sleepc 1.7(1.5) 1.0(1.3) 0.000 0.3(0.9) 0.000
Wake up at nightc 2.5(1.5) 1.3(1.3) 0.000 0.7(1.2) 0.008
Lack of good night sleepc 2.8(1.6) 1.5(1.5) 0.000 0.6(1.2) 0.000
Wake up tired 3.0(1.3) 1.7(1.5) 0.000 1.0(1.8) 0.01
Fatigued 1.8(1.5) 0.9(1.3) 0.000 0.3(0.7) 0.000
Reduced productivityd 1.9(1.1) 0.9(1.1) 0.000 0.2(0.6) 0.000
Reduced consentrationd 2.1(1.4) 1,0(1.2) 0.000 0.4(0.7) 0.000
Frustrated/restless/ irritabled 2.0(1.6) 0.9(1.3) 0.000 0.3(0.7) 0.003
Sadd 1.0(1.3) 0.5(1.0) 0.000 0.2(0.5) 0.003
Embarrassedd 0.8(1.0) 0.3(0.8) 0.001 0.1(0.3) 0.007
Subset
Rhinologica 1.9(1.0) 1.0(0.8) 0.001 0.4(0.4) 0.000
Ear/faceb 1.0(1.0) 0.5(0.7) 0.000 0.4(0.7) 0.2
Sleep functionc 2,3(1.3) 1.3(1.3) 0.000 0.5(0.9) 0.000
Psycological functiond 1.6(1.1) 0.7(1.0) 0.000 0.3(0.5) 0.000
Mean SNOT-20 score 1.8(0.8) 0.9(0.8) 0.000 0.4(0.5) 0.000
P- valueA is the p value for improvement in the patient group from preoperatively to postoperatively. P-valueB is p-value for a difference between postoperative
SNOT-20 in the patients compared to the control group
a Questions belonging to rhinologic subset
b Questions belonging to ear/facial subset
c Questions belonging to sleep function subset
d Questions belonging to psychological function subset
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Chronic rhinosinusitis (CRS)
Eight patients had earlier undergone sinus surgery because
of CRS. We compared the SNOT score and symptoms in
these patients with the other patients and found that the
CRS patients reported significantly more trouble in the
ear and face segment of SNOT-20. Preoperatively they re-
ported 1.9(SD1.0) versus 0.9(SD0.9) (p < 0.01) in the other
patients and postoperatively 1.2(SD1.1) versus 0.4(SD0.8)
(p < 0.05). Regarding the symptoms on VAS, patients with
previous surgery for CRS had significantly more trouble
with rhinosinusitis than the other patients had preopera-
tively and postoperatively. Preoperatively VAS score for
rhinosinusitis was 41(SD35) versus13 (SD25) in the other
patients, postoperatively the scores changed to 33(SD34)
versus 10(SD24). For all the other symptoms we found no
differences.
Gender
We found no significant difference between men and
women regarding mean pre- and postoperative SNOT-20
(p = 0.1 and p = 0.78). Evaluating the VAS scores pre and
postoperatively we found that the women in this study re-
port more symptoms preoperatively than the men but
postoperatively there were no significant differences be-
tween men and women. The women reported significantly
(p < 0.05) more trouble with nasal blockage, facial pres-
sure, sneezing, and reduced general condition than the
men. Average VAS score for all symptoms in women was
47 (SD15) preoperatively and average VAS score in men
was 35(SD18). The difference was significant preopera-
tively (p < 0.02). Postoperatively average VAS score was 14
(SD15) in both groups.
Patient satisfaction 6 months after surgery
Six months after surgery we asked the patients if they
were satisfied with the result. Sixty-two patients (62/86)
answered the question. Forty-seven (47/62) were satisfied
(76 %) and fifteen (15/62) were not (24 %). We found that
previous septoplasty patients had significantly greater
risk of being unsatisfied with the result after surgery
(p < 0.028). Six patients (6/13) with previous septoplasty
were not satisfied with the result 6 months after surgery
(46 %). Eight of the patients (8/51) without previous sur-
gery were not satisfied with the result 6 months after sur-
gery (16 %). We compared symptoms preoperatively and
postoperatively on VAS and found that patients who been
operated previously reported significantly (p < 0.05) more
trouble with headache (28 vs 15), facial pain (13 vs 4),
nasal secretions (35 vs 17), mouth breathing (36 vs 23)
and reduced general condition (20 vs 9) postoperatively
than the other patients.
Discussion
This study shows that nasal septoplasty leads to a better
sino-nasal Qol and a significant improvement for all
symptoms given on VAS. The patients do not reach the
same Qol postoperatively as healthy controls. The patient
group has a significantly lower sino-nasal Qol in three
of four subsets in SNOT-20 postoperatively. Regarding
symptoms on VAS, the patients reach the same level as
the healthy controls in 6 of 11 symptoms. For symptoms
as nasal blockage, change in sense of smell, nasal secre-
tions, oral breathing and reduced general condition we
find a greater symptom burden in the patient group
postoperatively.
The patients report a mean preoperative SNOT-20
score of 1.8. Comparing the preoperative results from the
SNOT-20 questionnaire with results from other studies
we see that the patients with septal deviations report Qol
at approximately the same level as patients with CRS [11]
and a worse SNOT-20 score than asthmatic patients who
report a mean SNOT-20 score of 1.3 [14].
Table 3 Symptoms on VAS in the patient group and the control group
Symptoms Mean Preoperatively VAS (SD ) Mean Postoperatively VAS (SD ) P-value1 Control group P-value2
Nasal blockage 71(SD20) 29(SD26) 0.000 9 (11) 0.000
Headache 33(SD30) 18(SD25) 0.000 16 (20) 0.5
Facial pain 16(SD24) 7(SD14) 0.000 9 (17) 0.4
Altered sense of smell 31(SD32) 12(SD24) 0.000 5 (9) 0.009
Nasal discharge 42(SD32) 22(SD29) 0.000 11 (19) 0.003
Sneezing 32(SD28) 17(SD23) 0.000 14 (15) 0.3
Trouble with rhinosinusitis 16(SD28) 4(SD12) 0.000 3 ( 7) 0.9
Cough 22(SD27) 9(SD17) 0.000 7 ( 9) 0.3
Snoring 54(SD33) 26(SD26) 0.000 26 (29) 0.8
Oral breathing 63(SD30) 23(SD27) 0.000 13 (22) 0.01
Reduced general health 47(SD31) 12(SD20) 0.000 5 ( 6) 0.007
P-value1 is the p-value for improvement from preoperatively to postoperatively. P-value 2 is the p-value for a difference in postoperative symptoms in the patients
compared to the controls
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Nasal septal surgery leads to a highly significant im-
provement in mean SNOT-20 score. For all subsets in
the questionnaire we find a highly significant improve-
ment. When comparing the postoperative results with
healthy controls we find that the patients reach the same
level as the controls in the ear and face subset of the
questionnaire where the symptom burden is comparable
in the groups. For the rhinologic -, sleep function-, and
the psychological subset there is a difference between
the groups postoperatively. The average improvement
on SNOT-20 was 0.9. Piccirillo et al report that a reduc-
tion on SNOT-20 equal 0.8 or better is regarded as clin-
ical significant [11]. Anyway, the patient group reaches a
mean SNOT-20 score of 0.9 postoperatively which rep-
resent a place between no symptoms and very mild
symptoms on the scale from zero to five.
Looking closer at the symptom scores given on VAS
we find that surgery has a highly significant effect on all
symptoms and it is confirmed that the main symptom in
patients with nasal septal deviations is nasal blockage.
The nasal blockage in the patient group may enhance
symptoms such as snoring, oral breathing and nasal dis-
charge, which consequently may reduce the general
health of the patients. Surgery leads to a highly signifi-
cant symptom improvement. Postoperatively, the patients
reach the same symptom level as the healthy controls in 6
of 11 symptoms, and all symptoms were reported as mild
on VAS postoperatively [13].
Baseline data show that some of the patients who
undergo nasal septoplasty have coexisting diseases such
as allergy, asthma, obstructive sleep apnea and CRS.
These are all conditions which may be influenced by
nasal blockage. It is easy to accept that allergic rhinitis
together with septal deviations can lead to more symp-
toms from the nose than these two conditions separ-
ately. The fact that 40 % of the patients report that they
have allergic rhinitis support this assumption; allergy
and septal deviations together render the patients moti-
vated for surgery. When we did sub analyses where we
compared Qol and postoperative symptoms in allergic
and non-allergic patients we found no differences be-
tween the groups on SNOT-20, but regarding nasal
blockage and facial pressure we found that the allergic
patients reported more symptoms on VAS than non-
allergic patients postoperatively. This difference is prob-
ably caused by nasal congestion due to allergy and is im-
portant to acknowledge by the surgeon and the patients.
Allergic patients might not respond as well as non-allergic
patients to septoplasty and they might profit from add-
itional preoperative investigations, for instance CT of the
nose and sinus, to improve the planning of the surgery.
Nevertheless, it is of great importance that the allergic
patients are treated medically also postoperatively to
optimize the outcome after surgery.
It is shown in an earlier study that asthmatic patients
have more symptoms of nasal blockage than non-
asthmatic patients [14] and that they need an open nose
to optimize the air for the lower airways. A blocked nose
with the consequent lack of cleaning, humidification and
warming of the inspired air [15] may harm the lungs and
lead to more troublesome asthma. Therefore, treatment of
nasal blockage in these patients is even more important.
We did sub analyses on the fifteen asthmatic patients (15/
95) in this study where we compared Qol and postopera-
tive symptoms on VAS in asthmatic patients with patients
without asthma. We found no significant differences
postoperatively indicating that asthma patients reach
the same QOL and symptom level as the other patients.
Snoring is considered problematic among our patients.
The sleep subset in SNOT-20 shows that patients with
indication for a septoplasty have problems with sleep
quality. Fifteen patients (15/91) reported they have ob-
structive sleep apnea. Twelve of these patients had
trouble using or trouble accepting the continuous posi-
tive airway pressure (CPAP) due to nasal blockage. After
surgery the patients with OSAS report improvement for
all symptoms on VAS but when we look separately at
snoring on VAS we find that the OSAS patients have
significantly more trouble with snoring postoperatively
than the other patients. This may be explained by a dif-
ferent anatomic configuration of the soft palate or oral
cavity that may lead to breathing problems during sleep.
Unfortunately, we have no documentation to prove this.
Many patients with CRS have a deviated nasal septum.
In this study, eight patients had previously undergone
sinus surgery with unsatisfactory results. Sub analyses of
the symptoms on VAS and SNOT-20showed that the
CRS patients responded similar to nasal septum surgery
as the other patients but report more trouble with rhino-
sinusitis preoperatively and postoperatively and more
trouble in the ear and face segment of SNOT 20. This is
comprehensible because symptoms of rhinosinusitis is
more expected in CRS patients than patients with a de-
viated nasal septum.
We see that more men than women undergo septum
surgery. The reason for this is not clear, but we think that
men tend to be involved in activities that are associated
with a higher risk for nasal traumas. Nevertheless, both
men and women respond to nasal septum surgery and
reach the same Qol and symptom level postoperatively.
The patients were asked if they were satisfied with the
result after surgery. 76 % answered yes and 24 % answered
no. This corresponds with other studies [6]. We did sub
analyses and found that 86 % of the patients who under-
went surgery for the first time were satisfied but only 54 %
of the patients who had undergone previous nasal septo-
plasty were satisfied. Patients who had undergone nasal
surgery previously also reported more symptoms on VAS
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postoperatively. This indicates that revision surgery is
more difficult and extra caution and exact planning is
paramount when doing revision nasal septoplasty.
The major strengths of this study are the pragmatic study
design based on prospective registry data in an everyday
clinical setting. All patients selected for surgery were asked
to participate. Eighty-seven of 91 patients who underwent
surgery came for the postoperative control and all patients
were at the out patient’s clinic when they reported their
symptoms which should minimize errors in their reporting.
This study has some limitations. We have not random-
ized the patients to other treatment options for compari-
son. The use of SNOT-20 as a tool to assess sino-nasal
Qol has some limitations due to lack of questions about
nasal obstruction and loss of smell and taste. However,
we compensate for this by evaluating nasal obstruction
and change of smell on VAS.
Conclusion
In this study we have shown that nasal septoplasty leads
to a better sino-nasal Qol and a highly significant symp-
tom improvement. The patients do not reach the same
Qol as healthy controls but they reach the same symp-
tom level in six of eleven symptoms. In average all
symptoms are reported as mild on VAS. Allergic patients
tend to have more trouble with nasal blockage and facial
pressure postoperatively than other patients and should
therefore have focus on medical treatment also postop-
eratively. Patients with obstructive sleep apnea syndrome
report more trouble with snoring postoperatively than
the other patients and alternative treatment options for
snoring may be considered in these patients.
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